Polydex Pharmaceuticals Limited
OTC: POLXF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- George G. Usher
- Employees
- 20
- Headquarters
- Toronto, Canada
- IPO year
- 1983
- Market cap
- $6.8M
- Website
- https://www.polydex.com
Loading POLXF…
Loading profile data…Frequently asked questions about POLXF
What does Polydex Pharmaceuticals Limited (POLXF) do?
Polydex Pharmaceuticals Limited (PPL), a Toronto, Canada-based company, was incorporated in 1979 and initially operated as Polydex Chemicals Limited before adopting its current name in March 1984. PPL specializes in the research, development, manufacturing, and global marketing of biotechnology-derived products for the human pharmaceutical secto...
Where does POLXF trade?
Polydex Pharmaceuticals Limited (POLXF) trades on the Other OTC.
What sector is POLXF in?
Polydex Pharmaceuticals Limited (POLXF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Polydex Pharmaceuticals Limited?
George G. Usher is the chief executive officer of Polydex Pharmaceuticals Limited (POLXF).
Where is Polydex Pharmaceuticals Limited headquartered?
Polydex Pharmaceuticals Limited is headquartered in Canada.
Does POLXF pay a dividend?
Polydex Pharmaceuticals Limited (POLXF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did POLXF go public?
Polydex Pharmaceuticals Limited (POLXF) completed its initial public offering in 1983.